Quarterly report · Q2
7730.TEDINET S100T9EX
Period2023-09-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.9bn | 2023-09-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥24.5bn | 2022-09-01 → 2023-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.0bn | 2022-09-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥4.2bn | 2023-09-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥3.5bn | 2022-09-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥4.6bn | 2023-09-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2022-09-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥4.5bn | 2023-09-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2022-09-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.2bn | 2023-09-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.0bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.6bn | 2022-09-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.2bn | 2023-09-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥2.6bn | 2022-09-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥56.2bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥55.0bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥50.7bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.6bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥5.1bn | at 2023-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥51.6bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥49.8bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥46.2bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥23.5bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥25.4bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥22.7bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.8bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.4bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.1bn | at 2022-08-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.6bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.8bn | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.1bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.0bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.6bn | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.1bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.3bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥32.41 | 2023-09-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.43 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.46 | 2022-09-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.04 | 2022-09-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.84 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.8% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.6% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.0% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-09-01 → 2024-02-29 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥5.1bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥5.1bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.0bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥5.0bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥5.0bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.9bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥3.8bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥3.8bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-09-01 → 2024-02-29 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-09-01 → 2024-02-29 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-09-01 → 2024-02-29 | ¥4.2bn |
| Reconciling Itemsreconciling | revenue | 2022-09-01 → 2023-02-28 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-09-01 → 2023-02-28 | −¥1m |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥4.7bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥4.7bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥1.3bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2022-09-01 → 2023-02-28 | ¥1m |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥1.3bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥3.2bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥3.2bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥917m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-02-28 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-02-28 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-09-01 → 2023-02-28 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-02-28 | ¥3.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人 トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)酒 井 博 康 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)浅 井 則 彦 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 12025000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 13908000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 24488000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 3512000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 4551000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 7995000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 2563000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 3191000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 5953000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 2394000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 3834000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 7408000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 46179000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 51593000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 49827000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 50745000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 56177000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 54977000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 26.04 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 32.41 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 60.46 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.910 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.918 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.906 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 3838000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 3625000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 8026000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -2643000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -3088000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -4016000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -1826000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -2097000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -3251000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 21358000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 22677000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 23798000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 12.84 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 16.43 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 106981502 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 106981502 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 106981502 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 106981502 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |